28th Sep 2021 13:51
DeepMatter Group PLC - Bristol-based company focused on digitising chemistry - Agrees to collaborate with Indian pharmaceutical company Dr Reddy's Laboratories Ltd. Plans to provide its DigitalGlassware platform to Dr Reddy's process development team as they seek to expand its chemistry procedures to handover to colleagues. Says this collaboration is part of the company's strategy to provide its DigitalGlassware platform to "major global contract research organisations where the need for reproducibility is paramount to accelerate the discovery of new drugs".
Chief executive of DeepMatter, Mark Warne, says: "We are focused on creating value for the world's largest [Contract Research Organisations] with our DigitalGlassware platform. We are working with them to firmly establish it as the go-to platform for capturing and structuring time-course sensor data in the lab, to enable improved insights for better productivity and discovery."
"Dr Reddy's are actively interested in the capture of parameters that they can utilise for their process development and modelling activities. We are working with them to see how DigitalGlassware, with the use of sensor devices, can aid in the capture of these important parameters and facilitate analysis of runs performed at Dr Reddy's," Warne adds.
Current stock price: 1.39 pence, up 6.9% on Tuesday
Year-to-date change: down 31%
By Scarlett Butler; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
DMTR.L